Literature DB >> 26303876

Polio eradication in the African Region on course despite public health emergencies.

Joseph C Okeibunor1, Martin C Ota2, Bartholomew D Akanmori3, Nicksy Gumede4, Keith Shaba4, Koffi I Kouadio4, Alain Poy4, Richard Mihigo3, Mbaye Salla4, Matshidiso R Moeti5.   

Abstract

The World Health Organization, African Region is heading toward eradication of the three types of wild polio virus, from the Region. Cases of wild poliovirus (WPV) types 2 and 3 (WPV2 and WPV3) were last reported in 1998 and 2012, respectively, and WPV1 reported in Nigeria since July 2014 has been the last in the entire Region. This scenario in Nigeria, the only endemic country, marks a remarkable progress. This significant progress is as a result of commitment of key partners in providing the much needed resources, better implementation of strategies, accountability, and innovative approaches. This is taking place in the face of public emergencies and challenges, which overburden health systems of countries and threaten sustainability of health programmes. Outbreak of Ebola and other diseases, insecurity, civil strife and political instability led to displacement of populations and severely affected health service delivery. The goal of eradication is now within reach more than ever before and countries of the region should not relent in their efforts on polio eradication. WHO and partners will redouble their efforts and introduce better approaches to sustain the current momentum and to complete the job. The carefully planned withdrawal of oral polio vaccine type II (OPV2) with an earlier introduction of one dose of inactivated poliovirus vaccine (IPV), in routine immunization, will boost immunity of populations and stop cVDPVs. Environmental surveillance for polio viruses will supplement surveillance for AFP and improve sensitivity of detection of polio viruses.
Copyright © 2016 World Health Organization. Published by Elsevier Ltd. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  IPV; Polio eradication; Polioviruses; WHO African Region; bOPV; tOPV, vaccines

Mesh:

Substances:

Year:  2015        PMID: 26303876     DOI: 10.1016/j.vaccine.2015.08.024

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  IMMUNIZATION AND VACCINE DEVELOPMENT: Progress towards High and Equitable Immunization Coverage in the Africa Region.

Authors:  Richard Mihigo; Joseph Okeibunor; Balcha Masresha; Pascal Mkanda; Alain Poy; Felicitas Zawaira; Joseph Cabore
Journal:  J Immunol Sci       Date:  2018-07-02

2.  Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region.

Authors:  Carol Tevi-Benissan; Joseph Okeibunor; Gaël Maufras du Châtellier; Afework Assefa; Joseph Nsiari-Muzenyi Biey; Dah Cheikh; Messeret Eshetu; Blanche-Philomene Anya; Halima Dao; Yusuf Nasir; Bartholomew Dicky Akanmori; Richard Mihigo
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

3.  Challenges of immunization in the African Region.

Authors:  Richard Mihigo; Joseph Okeibunor; Blanche Anya; Pascal Mkanda; Felicitas Zawaira
Journal:  Pan Afr Med J       Date:  2017-06-21

4.  Profile of polio-compatible cases in Nigeria, 2006-2016.

Authors:  Abdullahi Walla Hamisu; Faisal Shuaib; Ticha Muluh Johnson; Kehinde Craig; Braka Fiona; Richard Banda; Sisay G Tegegne; Ajiboye Oyetunji; Tesfaye B Erbeto; Peter Nsubuga; Rui Gama Vaz; Ado J G Muhamed; Adamu Usman
Journal:  BMC Public Health       Date:  2018-12-13       Impact factor: 3.295

5.  Efforts to Reach More Children with Effective Vaccines Through Routine Immunization in The WHO African Region: 2013-2015.

Authors:  Blanche Anya; Joseph Okeibunor; Richard Mihigo; Alain Poy; Felicitas Zawaira
Journal:  J Immunol Sci       Date:  2018-07-02

6.  Towards a Strategy for Reducing Missed Opportunities for Vaccination in Malawi: Implications of a Qualitative Health Facility Assessment.

Authors:  Joseph C Okeibunor; Ikechukwu Ogbuanu; Anya Blanche; Kwame Chiwaya; Geoffrey Chirwa; Zorodzai Machekanyanga; Richard Mihigo; Felicitas Zawaira
Journal:  J Immunol Sci       Date:  2018-07-02

7.  Vaccinations and Vaccinators' Tracking System in Island Settlements: CHAD 2017-2018.

Authors:  Ajiri Atagbaza; Joseph Okeibunor; Felix Amadou; Souley Kalilou; Aime Matela Esanga; Adama Nanko Bagayoko; Philbert Bohoussou; Obianuju Igweonu; Mahamat Mbodou Seid; Ahmad Jibril Aliyu; Elizabeth Benoit Ntezayabo; Mohamed Alimou Traore; Mwanza Nzioki; Adebola Olaleye; Adele Daleke Lisi Aluma; Djibrine Abakar Sedick; Adam Mahamat Seid; Mahamat Saleh Tahir; Narcisse de Medeiros; Bakoly Rabenarivo; Fabien Diomande; Pascal Mkanda
Journal:  J Immunol Sci       Date:  2021-04-12

8.  How can health systems be strengthened to control and prevent an Ebola outbreak? A narrative review.

Authors:  Krishna Regmi; Ruth Gilbert; Colin Thunhurst
Journal:  Infect Ecol Epidemiol       Date:  2015-11-24

9.  Violence, insecurity, and the risk of polio: A systematic analysis.

Authors:  Kia Guarino; Arend Voorman; Maxime Gasteen; Donte Stewart; Jay Wenger
Journal:  PLoS One       Date:  2017-10-11       Impact factor: 3.240

10.  Five-year experience of African Vaccination Week implemented by the WHO Regional Office.

Authors:  Joseph Okeibunor; Richard Mihigo; Blanche Anya; Felicitas Zawaira
Journal:  J Immunol Sci       Date:  2018-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.